| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9692 | 
      | Human Intestinal Absorption | HIA+ | 1.0000 | 
      | Caco-2 Permeability | Caco2+ | 0.8223 | 
      | P-glycoprotein Substrate | Substrate | 0.7126 | 
      | P-glycoprotein Inhibitor | Inhibitor | 0.7243 | 
                                                     | Non-inhibitor | 0.8906 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.7693 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.8710 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8337 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.9327 | 
      | CYP450 3A4 Substrate | Substrate | 0.7512 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9533 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9434 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9412 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.7874 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8711 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9270 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9562 | 
                                                                    | Non-inhibitor | 0.7248 | 
      | AMES Toxicity | Non AMES toxic | 0.9182 | 
      | Carcinogens | Non-carcinogens | 0.9568 | 
      | Fish Toxicity | High FHMT | 0.9924 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9452 | 
      | Honey Bee Toxicity | High HBT | 0.8027 | 
      | Biodegradation | Not ready biodegradable | 0.9596 | 
      | Acute Oral Toxicity | IV | 0.6859 | 
      | Carcinogenicity (Three-class) | Non-required | 0.4722 |